Please login to the form below
Pfizer revenue
This page shows the latest Pfizer revenue news and features for those working in and with pharma, biotech and healthcare.
Pfizer's 2021 revenue predictions soar to $82bn
Strong third-quarter revenues of $24.1bn lifted by sales of its BioNTech-partnered COVID-19 vaccine Comirnaty see Pfizer raise its 2021 revenue guidance to $82bn. ... Pfizer is having a good year. Following third-quarter sales figures that beat even the
Latest news
-
Price hike for Pfizer/BioNTech COVID-19 vaccine as UK orders boosters for 2022
Pfizer also expects revenue for Comirnaty to top out at $33.5bn by the end of 2021. ... The body suggests that Pfizer/BioNTech and Moderna are charging governments as much as $41bn above the estimated cost of production.
-
Pfizer lifts 2021 guidance as sales of its BioNTech-partnered vaccine continue to climb
For its 2021 revenue forecast, Pfizer raised its guidance to between $78bn and $80bn, up from the previous forecast of between $70.5bn and $72.5bn. ... Pfizer also updated revenue assumptions related to BNT162b2, now expecting the vaccine to bring in
-
Pfizer’s COVID-19 vaccine yields $3.5bn in first quarter sales
Looking ahead, Pfizer has said that it will raise its guidance range for its full-year revenue, increasing its forecast to between $70.5bn to $72.5bn, from the previous guidance ... Following these adjustments, Pfizer expects revenue from its COVID-19
-
Pfizer raises forecast following growth of biopharma business
Pfizer CEO Albert Bourla. Pfizer’s prostate cancer therapy Xtandi (enzalutamide) also grew in alliance revenues by 25% to $225m. ... On the flip-side, Pfizer reported a decline in revenue for its Upjohn generics business, which was down 26% in the
-
Fertility drugs drive healthcare growth at Merck KGaA
Merck is also banking on a $2.85bn immuno-oncology deal with Pfizer - signed in November 2014 - to help drive growth in the coming years. ... The deal gives Merck a revenue stream from co-promotion of Pfizer's lung cancer therapy Xalkori and the
More from news
Approximately 1 fully matching, plus 18 partially matching documents found.
Latest Intelligence
-
Pharma deals during April 2013
Pfizer has so far received $60m in upfront and milestone payments from Merck and will be eligible for additional milestone payments. ... Merck and Pfizer will share potential revenue and certain costs on a 60/40 percent basis.
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
Latest from PMHub
-
Three strategies for managing loss of exclusivity successfully
11. Since losing exclusive rights in 2017, Pfizer undertook an over-the-counter switching strategy to guard against revenue loss. ... RESULT: Pfizer still holds a lead in the erectile dysfunction market even as generics erode sales.
-
Three strategies for managing loss of exclusivity successfully
Since losing exclusive rights in 2017, Pfizer undertook an over-the-counter switching strategy to guard against revenue loss. ... RESULT: Pfizer still holds a lead in the erectile dysfunction market even as generics erode sales.
-
How do you define a biotech company?
Johnson &Johnson and Pfizer are two of the largest pharma companies in the world by revenue but both have numerous biological therapies. ... Roche define themselves as the “largest biotech in the world” and sit nestled between Johnson &Johnson and
More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.
Subscribe to our email news alerts
- Contagious Conversations: Exploring Infectious Disease in the Digital Age
- Austrian State Secretary to speak at FlyPharma Europe 2023
- Further data for AstraZeneca/Daichii Sankyo’s Enhertu for breast cancer requested by NICE
- Gritstone Bio receives $433m BARDA contract for COVID-19 vaccine candidate
- EDX Medical Group develops multi-disease 'point-of-care' rapid tests for cancer, infections and cardiovascular conditions
- ScreenPoint Medical to showcase AI software at European scientific meeting
No results were found
PMHub
Lucid Group Communications Limited
WE’RE ON A MISSION
To transform lives through communication that changes behaviour and improves health outcomes....
Latest intelligence
- The importance of accelerating clinical trial diversity
- Diversity shouldn’t be an afterthought – it’s an investment in the credibility of scientific endeavour...
- Digital Opinion Leaders: The Role of Influencers in Medical Communications
- There are many informed, knowledgeable HCPs who talk about a disease state online, but not all of them are influencers. This paper explores who digital opinion leaders are and how...
- Creating Hope Though Action – World Suicide Prevention Day
- At Mednet Group, we believe that actions speak louder than words. That's why we're getting behind this year's Suicide Prevention Day campaign of 'creating hope through action'....
